Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03778307 · ClinicalTrials.gov registry record

Key Dimensions of PTSD and ED

A clinical trial of PTSD and Trauma, sponsored by University of California, Los Angeles.

Completed
Registry status
168
Enrollment target
1
Study location

NCT03778307 is a study of PTSD and Trauma that has completed, run by University of California, Los Angeles. The registered enrollment target is 168 participants, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03778307, a study of PTSD and Trauma, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
168 participants
Enrollment target
1
Study location

Study Summary

This study will test whether endothelial dysfunction could be the early subclinical mechanism by which posttraumatic stress disorder (PTSD) increases cardiovascular disease (CVD) risk, and whether posttraumatic fear-a key component of PTSD-or another PTSD dimension could be the target to offset that risk. The results of this study may help trauma-exposed individuals who are at risk of having CVD events.

Interventions

  • BEHAVIORAL Psychophysiological fear conditioning and extinction task
  • BEHAVIORAL Eyetracking task

Study Locations (1)

California

  • UCLA - Los Angeles

Trial Details

FieldValue
Enrollment Target 168 participants
Start Date 2019-11-20
Est. Completion 2025-06-30

What the Registry Record Tells You About NCT03778307

The ClinicalTrials.gov registry entry for NCT03778307 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 168 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (44% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with PTSD appearing as the primary indexed condition, and to 2 interventions - of which Psychophysiological fear conditioning and extinction task is the first listed.

NCT03778307 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03778307 about?

NCT03778307 is a clinical study titled "Key Dimensions of PTSD and ED". This study will test whether endothelial dysfunction could be the early subclinical mechanism by which posttraumatic stress disorder (PTSD) increases cardiovascular disease (CVD) risk, and whether posttraumatic fear-a key component of PTSD-or another PTSD dimension could be the target to offset that...

What is the current status of trial NCT03778307?

This trial is currently completed. The enrollment target is 168 participants. The study started on 2019-11-20. Estimated completion is 2025-06-30.

What conditions does trial NCT03778307 study?

This clinical trial studies the following conditions: PTSD, Trauma, Endothelial Dysfunction.

What interventions are being tested in trial NCT03778307?

The interventions under investigation include: Psychophysiological fear conditioning and extinction task (BEHAVIORAL), Eyetracking task (BEHAVIORAL).

Who is sponsoring clinical trial NCT03778307?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03778307 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for PTSD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.